DWS ESG Biotech LC
- ISIN
- DE0009769976
- Provider
- DWS Investment GmbH
- Close Price
- €340.01 *
- Lipper Rating
- ESG Score
- Characteristics
- Sustainable
* Data as of 11 September 2026
Performance
Loading...
| Total | p.a. | |
|---|---|---|
| YTD | +8.54% | — |
| 1 Year | +34.83% | +34.83% |
| 3 Years | +38.32% | +11.41% |
| 5 Years | +24.65% | +4.50% |
| 10 Years | +97.23% | +7.02% |
Past performance is not a reliable indicator of future results. The value of an investment and the income from it can fall as well as rise.
Key Facts
| Asset Class | Equity |
| Holdings Classification | Equity United States Multi-Cap Growth |
| Geographical Focus | United States of America |
| Fund Size | €377,377,183 |
| Total Expense Ratio | 1.50% |
| Currency | EUR |
| Domicile | DE |
| Managementstyle | Active |
| SFDR Article | Article 8 |
Country Exposure
United States
84.2%
Netherlands
6.6%
United Kingdom
2.5%
Denmark
2.2%
Switzerland
1.9%
Other
2.7%
Description
The fund is actively managed and not managed with reference to a benchmark. The fund promotes environmental and social characteristics and is subject to the disclosure requirements of a financial product in accordance with Article 8(1) of Regulation (EU) 2019/2088 on sustainability-related disclosur...